This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Suzhou Institute of Materia Medica. Active years: 2024.
Company Filing History:
1 out of 3,341 
1 out of 1 Years Active: 2024
Title: The Innovations of Lianghe Mei
Introduction
Lianghe Mei is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors that target histone acetyltransferases (HATs). His work has implications for the treatment of various diseases related to HAT activity.
Latest Patents
Lianghe Mei holds a patent for a histone acetyltransferase (HAT) inhibitor. This patent discloses a compound represented by a specific general formula, along with various forms such as pharmaceutically acceptable salts, stereoisomers, and isotope-labeled compounds. The invention includes a preparation method and a pharmaceutical composition that can be used in the treatment of HAT-related diseases or conditions.
Career Highlights
Throughout his career, Lianghe Mei has worked at prestigious institutions, including the Chinese Academy of Sciences and the Suzhou Institute of Materia Medica. His research has focused on the biochemical mechanisms of histone modification and its implications for health and disease.
Collaborations
Lianghe Mei has collaborated with notable colleagues in his field, including Bing Zhou and Cheng Luo. Their joint efforts have contributed to advancements in understanding the role of histone acetylation in various biological processes.
Conclusion
Lianghe Mei's innovative work in developing HAT inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies in treating HAT-related diseases.